Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

EmPhAsIS: Empowering Pharmacists in Asthma Management Through Interactive SMS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02170883
Recruitment Status : Active, not recruiting
First Posted : June 23, 2014
Last Update Posted : September 20, 2018
Sponsor:
Collaborators:
WelTel
College of Pharmacists of British Columbia
Canadian Institutes of Health Research (CIHR)
Information provided by (Responsible Party):
Mary De Vera, University of British Columbia

Brief Summary:
Between 8% and 12% of Canadians suffer from asthma. Although there are effective and inexpensive treatments, adherence to asthma treatment is amongst the lowest for all chronic diseases.The purpose of this study is to determine whether enhancing the role of community pharmacists in asthma management using interactive short messaging service (SMS) with asthma patients is a cost-effective model that will improve adherence to inhaled corticosteroid medications compared to usual care.

Condition or disease Intervention/treatment Phase
Asthma Other: Interactive SMS Other: Usual care Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 370 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: EmPhAsIS: Empowering Pharmacists in Asthma Management Through Interactive SMS
Study Start Date : May 2015
Estimated Primary Completion Date : March 2019
Estimated Study Completion Date : March 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Asthma

Arm Intervention/treatment
Experimental: Interactive SMS
Intervention with interactive SMS (text messaging) by which patients are asked to disclose their level of agreement with the following statement "I follow my asthma medication plan" and pharmacist follow-up
Other: Interactive SMS
Active Comparator: Usual care
Pharmacist conducted patient education, counseling and action-plan
Other: Usual care



Primary Outcome Measures :
  1. Adherence to inhaled corticosteroid medication [ Time Frame: 12 months ]
    Adherence assessed by medication possession ratio


Secondary Outcome Measures :
  1. Asthma control [ Time Frame: Baseline ]
    Asthma control assessed by the Asthma Control Test

  2. Asthma control [ Time Frame: 6 months ]
    Asthma control assessed by the Asthma Control Test

  3. Asthma control [ Time Frame: 12 months ]
    Asthma control assessed by the Asthma Control Test

  4. Quality of life measured by the Asthma Quality of Life Questionnaire [ Time Frame: Baseline ]
    Quality of life measured by the Asthma Quality of Life Questionnaire

  5. Quality of life measured by the Asthma Quality of Life Questionnaire [ Time Frame: 3 months ]
    Quality of life measured by the Asthma Quality of Life Questionnaire

  6. Quality of life measured by the Asthma Quality of Life Questionnaire [ Time Frame: 12 months ]
    Quality of life measured by the Asthma Quality of Life Questionnaire

  7. Health care resource utilization [ Time Frame: 12 months ]
    Asthma-related hospital admissions and emergency department visits

  8. Use of reliever medication for acute asthma attacks [ Time Frame: 12 months ]
    Use of reliever medication for acute asthma attacks



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   14 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • individuals who fill a (incident or prevalent) prescription for inhaled corticosteroids (either monotherapy or in combination inhaler with long-acting beta-agonists) who have been diagnosed by a doctor as having asthma
  • possessing a cell-phone with ability to send/receive text messages
  • residing in British Columbia (BC), Canada and planning to reside in BC for the next 12 months
  • registered with the medical services plan (MSP, the provincial insure of medically-required services) in the past 12 months, and planning to remain registered for the next 12 months
  • designated pharmacy being the main drugstore for patient
  • not participating in another interventional study
  • consent to participate in the study.

Exclusion Criteria:

  • Unable to communicate in English
  • Under 14 years of age

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02170883


Locations
Layout table for location information
Canada, British Columbia
UBC
Vancouver, British Columbia, Canada, V6T 1Z3
Sponsors and Collaborators
University of British Columbia
WelTel
College of Pharmacists of British Columbia
Canadian Institutes of Health Research (CIHR)
Investigators
Layout table for investigator information
Principal Investigator: Mary De Vera, PhD University of British Columbia

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Mary De Vera, Assistant Professor, University of British Columbia
ClinicalTrials.gov Identifier: NCT02170883     History of Changes
Other Study ID Numbers: H14-01451
First Posted: June 23, 2014    Key Record Dates
Last Update Posted: September 20, 2018
Last Verified: September 2018

Keywords provided by Mary De Vera, University of British Columbia:
asthma
mHealth
cluster randomized controlled trial
pharmacy practice
pharmacist

Additional relevant MeSH terms:
Layout table for MeSH terms
Asthma
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases